Allison E. Aiello, Mary Ganguli, Sophie Carles, Jessica W. Lo, Jorge J. Llibre-Guerra, Ma Shwe Zin Nyunt, Linda Lam, Blossom C. M. Stephan, Mindy J. Katz, Wai Chi Chan, Ki Woong Kim, Yvonne Leung, Steve R. Makkar, Kaarin J. Anstey, CuilingWang, Seung Wan Suh, John D. Crawford, Mary N. Haan, Fiona E. Matthews, Adolfo J. Valhuerdi-Cepero, Henry Brodaty, Qi Gao, Alexander Pabst, Breno S. Diniz, Susanne Roehr, Steffi G. Riedel-Heller, Karen Ritchie, Mary Yannakoulia, Ada Fung, Mary H. Kosmidis, Ji Won Han, Julian N. Trollor, Simon Easteal, Annalisa Davin, Tze Pin Ng, Beth E. Snitz, Roberta Vaccaro, Darren M. Lipnicki, Juan J. Llibre-Rodriguez, Maria Fernanda Lima-Costa, Perminder S. Sachdev, Nikolaos Scarmeas, Richard B. Lipton, Nicole A. Kochan, Erico Castro-Costa, Tiffany F. Hughes, Nicolas Cherbuin, Carol Brayne, Isabelle Carrière, Kristina Dang, Antonio Guaita, University of New South Wales [Sydney] (UNSW), Fundação Oswaldo Cruz (FIOCRUZ), Réseau International des Instituts Pasteur (RIIP), University of Toronto, Center For Addiction and Mental Health, University of Cambridge [UK] (CAM), Newcastle University [Newcastle], University of Havana (Universidad de la Habana) (UH), University of California [San Francisco] (UCSF), University of California, Universidad de Matanzas, Yeshiva University, NY, Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital de la Colombière, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS (U1153 / UMR_A_1125 / UMR_S_1153)), Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Université Paris Descartes - Paris 5 (UPD5), National and Kapodistrian University of Athens (NKUA), Columbia University [New York], Harokopio University of Athens, Aristotle University of Thessaloniki, The Chinese University of Hong Kong [Hong Kong], The Hong Kong Polytechnic University [Hong Kong] (POLYU), Golgi Cenci Foundation, Seoul National University [Seoul] (SNU), Seoul National University Hospital, Universität Leipzig [Leipzig], University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), Youngstown State University (YSU), Neuroscience Research Australia (NeuRA), Australian National University (ANU), University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), National University of Singapore (NUS), University of Nottingham Malaysia Campus, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), and Le Couteur, David
We aimed to examine the relationship between Apolipoprotein E ε4 (APOE*4) carriage on cognitive decline, and whether these associations were moderated by sex, baseline age, ethnicity, and vascular risk factors. Participants were 19,225 individuals aged 54–103 years from 15 longitudinal cohort studies with a mean follow-up duration ranging between 1.2 and 10.7 years. Two-step individual participant data meta-analysis was used to pool results of study-wise analyses predicting memory and general cognitive decline from carriage of one or two APOE*4 alleles, and moderation of these associations by age, sex, vascular risk factors, and ethnicity. Separate pooled estimates were calculated in both men and women who were younger (ie, 62 years) and older (ie, 80 years) at baseline. Results showed that APOE*4 carriage was related to faster general cognitive decline in women, and faster memory decline in men. A stronger dose-dependent effect was observed in older men, with faster general cognitive and memory decline in those carrying two versus one APOE*4 allele. Vascular risk factors were related to an increased effect of APOE*4 on memory decline in younger women, but a weaker effect of APOE*4 on general cognitive decline in older men. The relationship between APOE*4 carriage and memory decline was larger in older-aged Asians than Whites. In sum, APOE*4 is related to cognitive decline in men and women, although these effects are enhanced by age and carriage of two APOE*4 alleles in men, a higher numbers of vascular risk factors during the early stages of late adulthood in women, and Asian ethnicity.